The DOI matches its Crossref record; 218 of the 228 references it cites were found in a registry or an index.
Microsatellite Instability in Colorectal Cancer
Open accessAbstract
Microsatellite instability (MSI) is a hypermutable phenotype caused by the loss of DNA mismatch repair activity. MSI is detected in about 15% of all colorectal cancers; 3% are of these are associated with Lynch syndrome and the other 12% are caused by sporadic, acquired hypermethylation of the promoter of the MLH1 gene, which occurs in tumors with the CpG island methylator phenotype. Colorectal tumors with MSI have distinctive features, including a tendency to arise in the proximal colon, lymphocytic infiltrate, and a poorly differentiated, mucinous or signet ring appearance. They have a slightly better prognosis than colorectal tumors without MSI and do not have the same response to chemotherapeutics. Discovery of MSI in colorectal tumors has increased awareness of the diversity of colorectal cancers and implications for specialized management of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“however, are commonly identified through separate MSI analysis and/or additional immunohistochemical staining for mismatch repair enzymes in pathology diagnostics2,3,51.”
From Self-supervised learning reveals clinically relevant histomorphological patterns for therapeutic strategies in colon cancer (2025) · cites this paper as [51]
The cited source says what the claim attributes to it.
In the citing paper
“MSI-high tumors have been linked to a favorable prognosis2,51, characterized by lower differentiation grade, increased T-cell infiltration, and reduced susceptibility to invasiveness and KRAS mutation51”
From Self-supervised learning reveals clinically relevant histomorphological patterns for therapeutic strategies in colon cancer (2025) · cites this paper as [51]
In the citing paper
“Microsatellite instability (MSI) caused by dysfunctional mismatch repair (dMMR) is detected in approximately 15% of all CRC and in nearly all cases with Lynch syndrome [126].”
From Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies (2021) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Self-citationUmar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., Fishel, R. A., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,181
Self-citation
Cited by
Sorted by citations
Items 501–600 of 1,002
Colorectal cancer surgery remains effective with rising patient age
Nitsche, U., Späth, C., Müller, T. C., Maak, M., Janssen, K., Wilhelm, D., Kleeff, J. H., & Bader, F. G. (2014) · International Journal of Colorectal Disease · doi:10.1007/s00384-014-1914-y · Cited by 42
Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
Draht, M. X. G., Goudkade, D., Koch, A., Grabsch, H. I., Weijenberg, M. P., van Engeland, M., Melotte, V., & Smits, K. M. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0461-8 · Cited by 41
Song, M., Ou, F., Zemla, T., Hull, M. A., Shi, Q., Limburg, P. J., Alberts, S. R., Sinicrope, F. A., Giovannucci, E. L., Blarigan, E. L. V., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32113 · Cited by 42
A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century
Kumar, R., Harilal, S., Carradori, S., & Mathew, B. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666201026143757 · Cited by 44
Limsui, D., Vierkant, R. A., Tillmans, L. S., Wang, A. H., Weisenberger, D. J., Laird, P. W., Lynch, C. F., Anderson, K. E., French, A. J., Haile, R. W., et al. (2011) · Gut · doi:10.1136/gutjnl-2011-300719 · Cited by 42
Rankin, A., Klempner, S. J., Erlich, R., Sun, J. X., Grothey, A., Fakih, M., George, T. J., Lee, J., Ross, J. S., Stephens, P. J., et al. (2016) · The Oncologist · doi:10.1634/theoncologist.2016-0148 · Cited by 40
Colorectal Cancer: From Genetic Landscape to Targeted Therapy
Bali, M. E., Bakkach, J., & Mechita, M. B. (2021) · Journal of Oncology · doi:10.1155/2021/9918116 · Cited by 43
Novel Methylation Biomarkers for Colorectal Cancer Prognosis
Gutierrez, A. R., Demond, H., Brebi, P., & Ili, C. (2021) · Biomolecules · doi:10.3390/biom11111722 · Cited by 41
Mengoli, V., Ceppi, I., Sanchez, A., Cannavò, E., Halder, S., Scaglione, S., Gaillard, P.-H. L., McHugh, P. J., Riesen, N., Pettazzoni, P., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2022111998 · Cited by 42
Molecular Testing of Solid Tumors
Igbokwe, A., & Lopez-Terrada, D. H. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2010-0413-rar.1 · Cited by 38
Kloten, V., Rose, M., Kaspar, S., von Stillfried, S. F., Knüchel, R., & Dahl, E. (2014) · Epigenetics · doi:10.4161/epi.32089 · Cited by 41
DNA Testing and Molecular Screening for Colon Cancer
Carethers, J. M. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.12.007 · Cited by 41
IL10R2 Overexpression Promotes IL22/STAT3 Signaling in Colorectal Carcinogenesis
Khare, V., Paul, G., Movadat, O., Frick, A. P., Jambrich, M., Krnjic, A., Marian, B., Wrba, F., & Gasché, C. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0031 · Cited by 41
Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer
Swets, M., Zaalberg, A., Boot, A., van Wezel, T., Frouws, M. A., Bastiaannet, E., Gelderblom, H. A. J., van de Velde, C. J. �., & Kuppen, P. J. K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010036 · Cited by 41
Deihimi, S., Lev, A., Slifker, M. J., Shagisultanova, E. I., Xu, Q., Jung, K., Vijayvergia, N., Ross, E. A., Xiu, J., Swensen, J. J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18098 · Cited by 42
Human Colorectal Cancer from the Perspective of Mouse Models
Šťastná, M., Janečková, L., Hrčkulák, D., Kříž, V., & Kořínek, V. (2019) · Genes · doi:10.3390/genes10100788 · Cited by 43
Bohaumilitzky, L., Doeberitz, M. V. K., Kloor, M., & Ahadova, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061741 · Cited by 40
The therapeutic and prognostic implications of immunobiology in colorectal cancer: a review
Zaborowski, A. M., Winter, D. C., & Lynch, L. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01475-x · Cited by 40
Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer
Zheng, Y., Fu, Y., Wang, P., & Ding, Z. (2022) · Disease Markers · doi:10.1155/2022/8270305 · Cited by 41
Telli, T. A., Bregni, G., Vanhooren, M., Saúde-Conde, R., Hendlisz, A., & Sclafani, F. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102460 · Cited by 43
Chung, J., Negm, L., Bianchi, V., Stengs, L. K., Das, A., Liu, Z. A., Sudhaman, S., Aronson, M. D., Brunga, L., Edwards, M., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02873 · Cited by 42
The Gut Microbiome and Colorectal Cancer: An Integrative Review of the Underlying Mechanisms
Karam, F., Deghel, Y. E., Iratni, R., Dakroub, A. H., & Eid, A. H. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01683-9 · Cited by 46
Luo, C., Zhang, R., Guo, R., Wu, L., Xue, T., He, Y., Jin, Y., Zhao, Y., Zhang, Z., Zhang, P., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.007 · Cited by 37
Connexins in colorectal cancer pathogenesis
Sirnes, S., Lind, G. E., Bruun, J., Fykerud, T. A., Mesnil, M., Lothe, R. A., Rivedal, E., Kolberg, M., & Leithe, E. (2014) · International Journal of Cancer · doi:10.1002/ijc.28911 · Cited by 40
Sessile serrated adenomas in the proximal colon are likely to be flat, large and occur in smokers
Rustagi, T. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i32.5271 · Cited by 40
Clinical applications of next-generation sequencing in colorectal cancers
Kim, T. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i40.6784 · Cited by 42
Surmann, E.-M., Voigt, A. Y., Michel, S., Bauer, K. H., Reuschenbach, M., Ferrone, S., Doeberitz, M. V. K., & Kloor, M. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1638-4 · Cited by 40
Promoter CpG Island Methylation Markers in Colorectal Cancer: The Road Ahead
Draht, M. X. G., Riedl, R. G., Niessen, H. E. C., Carvalho, B. G., Meijer, G. A., Herman, J. G., van Engeland, M., Melotte, V., & Smits, K. M. (2012) · Epigenomics · doi:10.2217/epi.12.9 · Cited by 40
Clinical Proteomics in Colorectal Cancer, a Promising Tool for Improving Personalised Medicine
Chauvin, A., & Boisvert, F. (2018) · Proteomes · doi:10.3390/proteomes6040049 · Cited by 41
Gasiulė, S., Dreižė, N., Kaupinis, A., Ražanskas, R., Čiupas, L., Stankevičius, V., Kapustina, Ž., Laurinavičius, A., Valius, M., & Vilkaitis, G. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122115 · Cited by 40
Promising Colorectal Cancer Biomarkers for Precision Prevention and Therapy
Turano, M., Delrio, P., Rega, D., Cammarota, F., Polverino, A., Duraturo, F., Izzo, P., & Rosa, M. D. (2019) · Cancers · doi:10.3390/cancers11121932 · Cited by 40
Auslander, N., Wolf, Y. I., & Koonin, E. V. (2020) · Nature Communications · doi:10.1038/s41467-020-15094-2 · Cited by 41
Cuéllar-Núñez, M. L., Loarca-Piña, G. F., Berhow, M. A., & de Mejı́a, E. G. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104270 · Cited by 40
Improving Care for Patients Living with Prolonged Incurable Cancer
Stegmann, M., Geerse, O. P., van Zuylen, L., Nekhlyudov, L., & Brandenbarg, D. (2021) · Cancers · doi:10.3390/cancers13112555 · Cited by 40
Wang, H., Ding, Y., Chen, Y., Jiang, J., Chen, Y., Lu, J., Kong, M., Mo, F., Huang, Y., Zhao, W., et al. (2021) · Gastric Cancer · doi:10.1007/s10120-021-01201-9 · Cited by 41
Chen, X., He, L., Liu, L., Li, S., Li, S., Zhang, Y., Liu, Z., Huang, Y., Mao, Y., & Chen, X. (2022) · European Radiology · doi:10.1007/s00330-022-08954-6 · Cited by 40
Isaksson‐Mettävainio, M., Palmqvist, R., Dahlin, A. M., Guelpen, B. R. V., Rutegård, M., Öberg, Å., & Henriksson, M. L. (2011) · International Journal of Cancer · doi:10.1002/ijc.26473 · Cited by 40
Swets, M., Martínez, C. G., van Vliet, S., van Tilburg, A., Gelderblom, H. A. J., Marijnen, C. A. M., van de Velde, C. J. �., & Nagtegaal, I. D. (2022) · Histopathology · doi:10.1111/his.14710 · Cited by 41
Clinical Subtypes and Molecular Characteristics of Serrated Polyposis Syndrome
Guarinós, C., Sánchez–Fortún, C., Soler, M. R., Pérez–Carbonell, L., Egoavil, C. M., Juárez, M., Serradesanferm, A., Bujanda, L., Fernández‐Bañares, F., Cubiella, J., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.045 · Cited by 39
Familial colorectal cancer type X: genetic profiles and phenotypic features
Valentin, M. D., Therkildsen, C., da Silva, S., & Nilbert, M. C. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.49 · Cited by 41
Hinrichsen, I., Brieger, A., Trojan, J., Zeuzem, S., Nilbert, M. C., & Plotz, G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3299 · Cited by 39
Hamaya, Y., Guarinós, C., Tseng-Rogenski, S. S., Iwaizumi, M., Das, R., Jover, R., Castells, A., Llor, X., Andreu, M. G., & Carethers, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127591 · Cited by 39
Cell-surface markers for colon adenoma and adenocarcinoma
Sewda, K., Coppola, D., Enkemann, S. A., Yue, B., Kim, J., Lopez, A. S., Wojtkowiak, J. W., Stark, V. E., Morse, B. G., Shibata, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7402 · Cited by 39
Parallel G-quadruplexes formed by guanine-rich microsatellite repeats inhibit human topoisomerase I
Ogloblina, A. M., Bannikova, V. A., Khristich, A. N., Oretskaya, T. S., Геннадиевна, Я. М., & Dolinnaya, N. G. (2015) · Biochemistry (Moscow) · doi:10.1134/s0006297915080088 · Cited by 39
Kim, J. H., Bae, J. M., Cho, N., & Kang, G. H. (2016) · Oncotarget · doi:10.18632/oncotarget.7374 · Cited by 42
Dunne, P. D., McArt, D. G., O’Reilly, P. G., Coleman, H. G., Allen, W. L., Loughrey, M. B., Schaeybroeck, S. V., McDade, S. S., Salto‐Tellez, M., Longley, D. B., et al. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0302 · Cited by 39
Cohen, S. A., Turner, E. H., Beightol, M., Jacobson, A. L., Gooley, T. A., Salipante, S. J., Haraldsdóttir, S., Smith, C., Scroggins, S. M., Tait, J. F., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.004 · Cited by 39
Current and future biomarkers in the treatment of colorectal cancer
Cuyle, P.-J. A., & Prenen, H. (2016) · Acta Clinica Belgica · doi:10.1080/17843286.2016.1262996 · Cited by 40
Marginean, E. C., & Melosky, B. L. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0040-ra · Cited by 40
Sandberg, T. P., Oosting, J., van Pelt, G. W., Mesker, W. E., Tollenaar, R. A. �. �., & Morreau, H. (2018) · Oncotarget · doi:10.18632/oncotarget.25845 · Cited by 39
DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility
Pardini, B., Corrado, A., Paolicchi, E., Cugliari, G., Berndt, S. I., Bezieau, S., Bien, S. A., Brenner, H., Caan, B. J., Campbell, P. T., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32516 · Cited by 39
Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities
Jiao, R., Luo, H., Xu, W., & Ge, H. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s214579 · Cited by 39
Yokogawa, T., Yano, W., Tsukioka, S., Osada, A., Wakasa, T., Ueno, H., Hoshino, T., Yamamura, K., Fujioka, A., Fukuoka, M., et al. (2020) · Cancer Science · doi:10.1111/cas.14718 · Cited by 37
Deep Learning of Histopathological Features for the Prediction of Tumour Molecular Genetics
Murchan, P., O’Brien, C. P., O’Connell, S., McNevin, C. S., Baird, A., Sheils, O. M., Broin, P. Ó., & Finn, S. P. (2021) · Diagnostics · doi:10.3390/diagnostics11081406 · Cited by 39
Geng, L., Huehls, A. M., Wagner, J. M., Huntoon, C. J., & Karnitz, L. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028862 · Cited by 39
The Mystery of Mismatch Repair Deficiency: Lynch or Lynch-like?
Boland, C. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.03.014 · Cited by 39
Self-citationTajeddin, N. Z., Jahanifar, M., Bilal, M., Eastwood, M., & Rajpoot, N. (2024) · Medical Image Analysis · doi:10.1016/j.media.2023.103071 · Cited by 36
Cai, Z., Xu, Z., Chen, Y., Zhang, R., Guo, B., Chen, H., Ouyang, F., Chen, X., Chen, X., Liu, D., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001335 · Cited by 42
Wang, C., Liu, T.-C., Lai, P.-J., Muzakky, H., Wang, Y., Yu, M.-H., Wu, C.-H., & Chao, T. (2024) · Medical Image Analysis · doi:10.1016/j.media.2024.103372 · Cited by 41
Role of mitochondria in carcinogenesis.
Tokarz, P., & Błasiak, J. (2014) · Acta Biochimica Polonica · doi:10.18388/abp.2014_1829 · Cited by 38
Bazzocco, S., Dopeso, H., Cartón‐García, F., Macaya, I., Andretta, E., Chionh, F. J. M., Rodrigues, P., Garrido, M., Alazzouzi, H., Nieto, R., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2457 · Cited by 38
Sarı, A., Pollett, A. F., Eiriksson, L. R., Lumsden-Johanson, B., de Laar, E. V., Kazerouni, H., Salehi, A., Sur, M., Lytwyn, A., & Ferguson, S. E. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001220 · Cited by 38
Twist1 induces chromosomal instability (CIN) in colorectal cancer cells
Khot, M., Sreekumar, D., Jahagirdar, S., Kulkarni, A. M., Hari, K., Faseela, E. E., Sabarinathan, R., Jolly, M. K., & Sengupta, K. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa076 · Cited by 38
From APC to the genetics of hereditary and familial colon cancer syndromes
Olkinuora, A. P., Peltomäki, P., Aaltonen, L. A., & Rajamäki, K. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab208 · Cited by 41
Promising Epigenetic Biomarkers for the Early Detection of Colorectal Cancer: A Systematic Review
Anghel, S. A., Ioniță-Mîndrican, C.-B., Luca, I., & Pop, A. L. (2021) · Cancers · doi:10.3390/cancers13194965 · Cited by 40
Zhu, H., Hu, X., Feng, S., Jian, Z., Xu, X., Gu, L., & Xiong, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6419695 · Cited by 44
Park, J. H., Kim, E. Y., Luchini, C., Eccher, A., Tizaoui, K., Shin, J. I., & Lim, B. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052462 · Cited by 38
Strong Hereditary Predispositions to Colorectal Cancer
Hryhorowicz, S., Kaczmarek-Ryś, M., Lis, E., Porowski, J., Szuman, M., Grot, N., Kryszczyńska, A., Paszkowski, J., Banasiewicz, T., & Pławski, A. (2022) · Genes · doi:10.3390/genes13122326 · Cited by 38
Is Microsatellite Instability Really a Good Prognostic Factor of Colorectal Cancer?
Shin, U. S., Cho, S. S., Moon, S. M., Park, S. H., Jee, S. H., Jung, E.-J., & Hwang, D. (2014) · Annals of Coloproctology · doi:10.3393/ac.2014.30.1.28 · Cited by 37
Zhang, D., Ni, Q.-Q., Liang, Q.-Y., He, L.-L., Qiu, B.-W., Zhang, L.-J., Mou, T., Le, C., Huang, Y., Li, T., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02806-3 · Cited by 37
Colorectal cancer screening by colonoscopy: putting it into perspective
Vleugels, J. L. A., van Lanschot, M. C. J., & Dekker, E. (2015) · Digestive Endoscopy · doi:10.1111/den.12533 · Cited by 38
Kenyon, J. D., Fu, P., Lingas, K. T., Thomas, E. A., Saurastri, A., Guasch, G. L. S., Wald, D. N., & Gerson, S. L. (2012) · Blood · doi:10.1182/blood-2011-12-401950 · Cited by 37
Fricke, F., Lee, J., Michalak, M., Warnken, U. H., Haußer, I., Suarez‐Carmona, M., Halama, N., Schnölzer, M., Kopitz, J., & Gebert, J. F. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0169-y · Cited by 37
Galanopoulos, M., Tsoukalas, N., Papanikolaou, I. S., Tolia, M., Gazouli, M., & Mantzaris, G. J. (2017) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v9.i4.142 · Cited by 37
Colon cancer and immunotherapy—can we go beyond microsatellite instability?
Breakstone, R. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2020.03.08 · Cited by 39
Lumican, pro-tumorigenic or anti-tumorigenic: A conundrum
Appunni, S., Rubens, M., Ramamoorthy, V., Anand, V., Khandelwal, M., Saxena, A., McGranaghan, P., Odia, Y., Kotecha, R. R., & Sharma, A. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.12.011 · Cited by 37
Resistance to Cell Death in Mucinous Colorectal Cancer—A Review
O’Connell, E., Reynolds, I. S., McNamara, D. A., Burke, J. P., & Prehn, J. H. M. (2021) · Cancers · doi:10.3390/cancers13061389 · Cited by 37
MYO10 drives genomic instability and inflammation in cancer
Pozo, F. M., Geng, X., Tamagno, I., Jackson, M. W., Heimsath, E. G., Hammer, J. A., Cheney, R. E., & Zhang, Y. (2021) · Science Advances · doi:10.1126/sciadv.abg6908 · Cited by 36
Du, C., Zhao, J., Xue, W., Dou, F., & Gu, J. F. (2012) · Histopathology · doi:10.1111/his.12069 · Cited by 38
Luna‐Vital, D. A., de Mejı́a, E. G., & Loarca-Piña, G. F. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.02.021 · Cited by 36
Rebuzzini, P., Zuccotti, M., Redi, C. A., & Garagna, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2171-8 · Cited by 35
Swan, R. L., Alnabulsi, A., Cash, B., Alnabulsi, A., & Murray, G. I. (2016) · Oncotarget · doi:10.18632/oncotarget.10224 · Cited by 37
Lynch Syndrome: Genomics Update and Imaging Review
Cox, V. L., Bamashmos, A. S., Foo, W. C., Gupta, S., Yedururi, S., Garg, N., & Kang, H. C. (2018) · Radiographics · doi:10.1148/rg.2018170075 · Cited by 36
Mjelle, R., Sjursen, W., Thommesen, L., Sætrom, P., & Hofsli, E. (2019) · BMC Cancer · doi:10.1186/s12885-019-5330-0 · Cited by 35
Screening of MSI detection loci and their heterogeneity in East Asian colorectal cancer patients
Bai, W., Ma, J., Liu, Y., Liang, J., Wu, Y., Yang, X., Xu, E., Li, Y., & Xi, Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2111 · Cited by 35
Li, Z., Dai, H., Liu, Y., Pan, F., Yang, Y., & Zhang, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.697497 · Cited by 38
Contribution of Aurora-A and -B expression to DNA aneuploidy in gastric cancers
Honma, K., Nakanishi, R., Nakanoko, T., Ando, K., Saeki, H., Oki, E., Iimori, M., Kitao, H., Kakeji, Y., & Maehara, Y. (2013) · Surgery Today · doi:10.1007/s00595-013-0581-x · Cited by 36
Clinicopathologic and Molecular Characteristics of Synchronous Colorectal Cancers
Bae, J. M., Cho, N., Kim, T., & Kang, G. H. (2012) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e31823c46ce · Cited by 36
Chang, X., Wang, J., Zhang, G., Yang, M., Xi, Y., Xi, C., Chen, G., Nie, X., Meng, B., & Quan, X. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100914 · Cited by 35
Zumwalt, T. J., Wodarz, D., Komarova, N. L., Toden, S., Turner, J., Cardenas, J., Burn, J., Chan, A. T., Boland, C. R., & Goel, A. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0175 · Cited by 35
Self-citationHodel, K. P., de Borja, R., Henninger, E. E., Campbell, B. B., Ungerleider, N., Light, N. D., Wu, T., LeCompte, K. G., Goksenin, A. Y., Bunnell, B. A., et al. (2018) · eLife · doi:10.7554/elife.32692 · Cited by 35
Rath, A., Mishra, A., Ferreira, V. D., Hu, C., Omerza, G., Kelly, K., Hesse, A., Reddi, H. V., Grady, J. P., & Heinen, C. D. (2019) · Human Mutation · doi:10.1002/humu.23848 · Cited by 36
Hyperprogression after immunotherapy in patients with malignant tumors of digestive system
Ji, Z., Peng, Z., Gong, J., Zhang, X., Li, J., Lu, M. S., Lü, Z., & Shen, L. (2019) · BMC Cancer · doi:10.1186/s12885-019-5921-9 · Cited by 36
Tanaka, A., Zhou, Y., Ogawa, M., Shia, J., Klimstra, D. S., Wang, J. Y., & Roehrl, M. H. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229252 · Cited by 37
Larsson, C., Cordeddu, L., Siggens, L., Pandzic, T., Kundu, S., He, L., Ali, M. A., Pristovšek, N., Hartman, K., Ekwall, K., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00863-z · Cited by 35
Alizadeh, S., Esmaeili, A., & Omidi, Y. (2020) · PubMed Central · doi:10.22038/ijbms.2020.43016.10115 · Cited by 35
Wang, D., O’Rourke, D., Sánchez-García, J. F., Cai, T., Scheuenpflug, J., & Feng, Z. (2021) · BMC Cancer · doi:10.1186/s12885-021-08497-x · Cited by 35
Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer
Chuang, J., Tsai, H., Chen, P.-J., Chang, T., Su, W., Yeh, Y., Huang, C., & Wang, J. (2022) · Cells · doi:10.3390/cells11233744 · Cited by 34
Targeted Therapy in Metastatic Colorectal Cancer: Current Standards and Novel Agents in Review
DeStefanis, R. A., Kratz, J. D., Emmerich, P. B., & Deming, D. A. (2019) · Current Colorectal Cancer Reports · doi:10.1007/s11888-019-00430-6 · Cited by 34
Zhou, J., pour, A. F., Deirawan, H., Daaboul, F., Aung, T. N., Beydoun, R., Ahmed, F. S., & Chuang, J. H. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104726 · Cited by 35
Metadata
- Authors
- Boland, C. R., & Goel, A.
- Affiliations
- Baylor University Medical Center (US)
- Corresponding author
- Boland, C. Richard
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 138
- Issue
- 6
- Pages
- 2073-2087.e3
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC3037515
- OpenAlex
- W2094390470
- Cited by
- 2,456
- References
- 228
- Citations by year
- 2026: 140 · 2025: 201 · 2024: 202 · 2023: 191 · 2022: 257 · 2021: 211 · 2020: 194 · 2019: 160 · 2018: 140 · 2017: 115 · 2016: 112 · 2015: 117 · 2014: 111 · 2013: 100 · 2012: 94
- FWCI
- 11.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (R01 CA129286, R01 CA72851)
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- microsatellite instability, colorectal cancer, DNA mismatch repair, Lynch syndrome, MLH1 promoter methylation, CpG island methylator phenotype, proximal colon tumors, lymphocyte infiltration, mucinous tumors, signet ring cell carcinoma, prognosis, chemotherapy response
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Colorectal Neoplasms, Hereditary Nonpolyposis, Humans, Mutation, Phenotype, Risk Factors, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Treatment Outcome, Genetic Predisposition to Disease, Microsatellite Instability, DNA Mismatch Repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review